NYU Langone Health

Studies Indicate Environmental Factors Can Impact Urologic Health

Retrieved on: 
金曜日, 5月 3, 2024

Researchers will present environmental and urological health study findings in San Antonio, Texas, from May 3 to 6.

Key Points: 
  • Researchers will present environmental and urological health study findings in San Antonio, Texas, from May 3 to 6.
  • Stacy Loeb, MD, Urology and Population Health professor at NYU Langone Health, moderated a virtual press session with the abstract authors, providing key insights into their research.
  • “It’s great that these studies are happening so we can get a better sense of how some of these environmental factors may affect things like fertility and urological cancer risk,” said Dr. Loeb.
  • It sounds like, in these cases, more studies are needed to follow up on these findings on an individual level.”
    The following abstracts are covered in the moderated panel:

Emergency Departments Frequently Miss Signs of Epilepsy in Children

Retrieved on: 
水曜日, 5月 1, 2024

The work focuses on "nonmotor" seizures, which cause children to "zone out" and stare into space or fidget.

Key Points: 
  • The work focuses on "nonmotor" seizures, which cause children to "zone out" and stare into space or fidget.
  • To be diagnosed with the condition, a patient must have experienced a minimum of two seizures with no apparent cause.
  • Their analysis showed that emergency department physicians correctly identified only 33% of first-time nonmotor seizures, compared with 81% of first-time motor seizures.
  • According to the United States Centers for Disease Control and Prevention, epilepsy is one of the most common brain disorders in children, affecting 470,000 under age 17.

LifeMD to Participate in Upcoming Investor and Industry Conferences During May

Retrieved on: 
火曜日, 4月 23, 2024

Management will participate in a virtual panel titled Obesity Management with Coaching, Eating, and Lifestyle Management moderated by equity research analyst David Larsen.

Key Points: 
  • Management will participate in a virtual panel titled Obesity Management with Coaching, Eating, and Lifestyle Management moderated by equity research analyst David Larsen.
  • Management will be presenting a corporate overview and will be holding one-on-one meetings with investors.
  • LifeMD’s Chief Medical Officer Dr. Anthony Puopolo will speak about optimal obesity care on a panel with other thought leaders.
  • B. Riley Securities 24th Annual Institutional Investor Conference, May 22-23, 2024 at The Beverly Hilton in Beverly Hills.

Newsweek and Statista Announce Second Annual America’s Best Fertility Clinics Ranking

Retrieved on: 
水曜日, 4月 17, 2024

NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) -- Newsweek, the modern global digital news organization, in partnership with Statista, announced today the release of its America’s Best Fertility Clinics rankings.

Key Points: 
  • NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) -- Newsweek, the modern global digital news organization, in partnership with Statista, announced today the release of its America’s Best Fertility Clinics rankings.
  • This is Newsweek’s second annual fertility clinics rankings, which includes 125 of America’s best clinics.
  • With the rise of fertility treatments in America, Newsweek’s rankings provide adults with information about the top clinics to help start or grow their families.
  • “The second annual America’s Best Fertility Clinics ranking has taken on a new meaning to Newsweek due to recent current events.

United Therapeutics Announces World’s First Successful Xenothymokidney Transplant

Retrieved on: 
金曜日, 4月 26, 2024

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced the world’s first successful transplant of a UThymoKidney™, which the company produced, into a living person on April 12, 2024.

Key Points: 
  • United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced the world’s first successful transplant of a UThymoKidney™, which the company produced, into a living person on April 12, 2024.
  • (Photo: Business Wire)
    - The first-ever transplant of a xenothymokidney into a living human recipient;
    - The first-ever combined mechanical heart pump and organ transplant; and
    The transplant is the third xenotransplant using United Therapeutics’ xeno organs, following two successful UHeart™ transplants at the University of Maryland Medicine in 2022 and 2023.
  • United Therapeutics’ xenothymokidney, known by the proposed trade name UThymoKidney, is an investigational-stage xenokidney from a pig with a single genetic edit, together with tissue from the same pig’s thymus.
  • United Therapeutics is preparing for clinical trials of its xenokidney, xenothymokidney, and xenoheart products, following completion of ongoing preclinical studies required by the FDA.

InnoCaption Use Significantly Improves Smartphone Communication Experience for Deaf and Hard-of-Hearing Users

Retrieved on: 
木曜日, 4月 18, 2024

Only 59% of respondents reported using their smartphone “frequently” before using InnoCaption.

Key Points: 
  • Only 59% of respondents reported using their smartphone “frequently” before using InnoCaption.
  • This number jumped to 70% three months later after using InnoCaption.
  • Before using InnoCaption, 62% of respondents said they experienced considerable listening fatigue when making calls with their smartphone.
  • Prior to using InnoCaption, 66% of respondents said that they had to put in considerable effort when making calls on their smartphones.

First-Ever Combined Heart Pump and Pig Kidney Transplant Gives New Hope to Patient with Terminal Illness

Retrieved on: 
水曜日, 4月 24, 2024

NEW YORK, April 24, 2024 /PRNewswire/ -- Surgeons at NYU Langone Health performed the first-ever combined mechanical heart pump and gene-edited pig kidney transplant surgery in a 54-year-old woman with heart and kidney failure—a confluence of advances that showcase the possibility and hope of modern medicine.

Key Points: 
  • NEW YORK, April 24, 2024 /PRNewswire/ -- Surgeons at NYU Langone Health performed the first-ever combined mechanical heart pump and gene-edited pig kidney transplant surgery in a 54-year-old woman with heart and kidney failure—a confluence of advances that showcase the possibility and hope of modern medicine.
  • Doctors performed this feat in two stages: first surgically implanting the heart pump days before embarking on the landmark transplant, which included a gene-edited pig kidney and the pig's thymus gland to aid against rejection.
  • Before the procedure, patient Lisa Pisano, a New Jersey native, faced heart failure and end-stage kidney disease that required routine dialysis.
  • It is only the second known transplant of a gene-edited pig kidney into a living person, and the first with the thymus combined.

NYU Langone's Perlmutter Cancer Center Earns Redesignation as a Comprehensive Cancer Center from the National Cancer Institute

Retrieved on: 
木曜日, 4月 18, 2024

NEW YORK, April 18, 2024 /PRNewswire/ -- NYU Langone Health's Laura and Isaac Perlmutter Cancer Center has once again been designated as a Comprehensive Cancer Center, the highest ranking awarded by the National Cancer Institute and further validation that it provides state-of-the-art, research-based approaches to preventing, detecting, and treating cancer.

Key Points: 
  • NEW YORK, April 18, 2024 /PRNewswire/ -- NYU Langone Health's Laura and Isaac Perlmutter Cancer Center has once again been designated as a Comprehensive Cancer Center, the highest ranking awarded by the National Cancer Institute and further validation that it provides state-of-the-art, research-based approaches to preventing, detecting, and treating cancer.
  • Perlmutter Cancer Center is among only 56 institutions recognized across the nation for earning this elite distinction.
  • Perlmutter Cancer Center achieved its ranking by demonstrating success in the following areas:
    Developing and offering the most advanced therapies and innovative clinical trials.
  • Experts at Perlmutter Cancer Center have also implemented screening approaches to diagnose lung cancer in non-smokers.

Yosi Health Bolsters Leadership Team to Further Drive Innovation and Growth

Retrieved on: 
火曜日, 4月 16, 2024

NEW YORK, April 16, 2024 /PRNewswire/ -- Yosi Health, a leading provider of patient management solutions for healthcare practices, today announced the addition of new executives to join its leadership team. These strategic appointments will accelerate product development, forge new partnerships, drive customer success initiatives, amplify marketing efforts, and supercharge business development as Yosi Health continues to meet the growing demand for its platform.

Key Points: 
  • "With this incredible team of accomplished professionals from diverse backgrounds, we are well-positioned to cement our leadership in healthcare innovation."
  • Kelly Hsiung as Director of Marketing: Kelly leverages over 18 years of B2B & B2C marketing leadership experience across diverse industries like retail and healthcare, to amplify the Yosi Health brand and drive growth marketing initiatives across multiple channels.
  • By expanding the size and capabilities of its leadership team, Yosi Health is better positioned to meet the evolving needs of healthcare practices and drive continued innovation to help improve patient outcomes and reduce the cost of providing care.
  • For more information about the entire Yosi leadership team visit: https://yosi.health/about/leadership/

NYU Langone Neurologists Present Latest Clinical Findings & Research at AAN 2024

Retrieved on: 
土曜日, 4月 13, 2024

DENVER, April 13, 2024 /PRNewswire/ -- Experts from NYU Langone's Department of Neurology present their latest clinical findings and research discoveries at the American Academy of Neurology (AAN) 2024 Annual Meeting, April 13 to 18, in Denver.

Key Points: 
  • DENVER, April 13, 2024 /PRNewswire/ -- Experts from NYU Langone's Department of Neurology present their latest clinical findings and research discoveries at the American Academy of Neurology (AAN) 2024 Annual Meeting, April 13 to 18, in Denver.
  • U.S. News & World Report's "Best Hospitals" ranks NYU Langone the No.
  • Researchers at NYU Langone surveyed 90 clinicians, residents, and fellows to identify the best methods of showing neurologists that they are valued in order to improve their job satisfaction and reduce burnout.
  • Further research is warranted to validate these findings and their potential to enhance early detection and intervention strategies for Alzheimer's disease.